Portal de Periódicos da CAPES

Inhibition of the Ubiquitin-Proteasome System by Natural Products for Cancer Therapy

2010; Thieme Medical Publishers (Germany); Volume: 76; Issue: 11 Linguagem: Inglês

10.1055/s-0029-1240901

1439-0221

Sachiko Tsukamoto, Hideyoshi Yokosawa,

14-3-3 protein interactions

The ubiquitin-proteasome system plays a critical role in selective protein degradation and regulates almost all cellular events such as cell cycle progression, signal transduction, cell death, immune responses, metabolism, protein quality control, development, and neuronal function. The recent approval of bortezomib, a synthetic proteasome inhibitor, for the treatment of relapsed multiple myeloma has opened the way to the discovery of drugs targeting the proteasome and ubiquitinating and deubiquitinating enzymes as well as the delivery system. To date, various synthetic and natural products have been reported to inhibit the components of the ubiquitin-proteasome system. Here, we review natural products targeting the ubiquitin-proteasome system as well as synthetic compounds with potent inhibitory effects.